STRONG SITE SELECTION LEADS TO SUCCESS PRA Screens 5 Months Ahead of Schedule PR A HEAL TH SCIEN CES CASE STUDYTHE FUTURE OF CLINICAL DEVELOPMENT. PR A HEAL THSCIENCES CASE STUDY STRONG SITE SELECTION LEADS TO SUCCESS PRA Screens 5 Months Ahead of Schedule SITUATION PRA was selected to conduct a global Phase III gastrointestinal stromal tumors (GIST) study for a top 20 large pharmaceutical client. CHALLENGES GIST is less specialized in the

Join for free to read